{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:59:32Z","timestamp":1772456372645,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Being among the most common malignancies worldwide, hepatocellular carcinoma (HCC) accounting for the third cause of cancer mortality. The regulation of cell death is the most crucial step in tumor progression and has become a crucial target for nearly all therapeutic options. Cuproptosis, a copper-induced cell death, was recently reported in Science. However, its primary function in carcinogenesis is still unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Cuproptosis-related lncRNAs significantly associated with overall survival (OS) were screened by stepwise univariate Cox regression. The signature of cuproptosis-related lncRNAs for HCC prognosis was constructed by the LASSO algorithm and multivariate Cox regression. Further Kaplan\u2013Meier analysis, proportional hazards model, and ROC analysis were performed. Functional annotation was performed using gene set enrichment analysis (GSEA). The relationship between prognostic cuproptosis-related lncRNAs and HCC prognosis was further explored by GEPIA(\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/gepia.cancer-pku.cn\/\">http:\/\/gepia.cancer-pku.cn\/<\/jats:ext-link>\n                      ) online analysis tool. Finally, we used the ESTIMATE and XCELL algorithms to estimate stromal and immune cells in tumor tissue and cast each sample to infer the underlying mechanism of cuproptosis-related lncRNAs in the tumor immune microenvironment (TIME) of HCC patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four cuproptosis-related lncRNAs were used to construct a prognostic lncRNA signature, which was an independent factor in predicting OS in HCC patients. Kaplan\u2013Meier curves showed significant differences in survival rates between risk subgroups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). At the same time, we found that the expression levels of most immune checkpoint genes increased with increasing risk scores. Tumorigenesis and immunological-related pathways were primarily enhanced in the high-risk group, as determined by GSEA. The results of drug sensitivity analysis showed that compared with patients in the high-risk group, the IC50 values of erlotinib and lapatinib were lower in patients in the low-risk group, while the opposite was true for sunitinib, paclitaxel, gemcitabine, and imatinib. We also found that elevated\n                      <jats:italic>AL133243.2<\/jats:italic>\n                      expression was significantly associated with worse OS and disease-free survival (DFS), more advanced T stage and higher tumor grade, and reduced immune cell infiltration, suggesting that HCC patients with low\n                      <jats:italic>AL133243.2<\/jats:italic>\n                      expression in tumor tissues may have a better response to immunotherapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Collectively, the cuproptosis-associated lncRNA signature can serve as an independent predictor to guide individual treatment strategies. Furthermore,\n                      <jats:italic>AL133243.2<\/jats:italic>\n                      is a promising marker for predicting immunotherapy response in HCC patients. This data may facilitate further exploration of more effective immunotherapy strategies for HCC.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12859-022-05091-1","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T10:03:55Z","timestamp":1672740235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Chunhua","family":"Liu","sequence":"first","affiliation":[]},{"given":"Simin","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Liying","family":"Lai","sequence":"additional","affiliation":[]},{"given":"Jinyu","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Zhaofu","family":"Guo","sequence":"additional","affiliation":[]},{"given":"Zegen","family":"Ye","sequence":"additional","affiliation":[]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"issue":"1","key":"5091_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-019-0368-6","volume":"39","author":"RM Feng","year":"2019","unstructured":"Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun. 2019;39(1):1\u201312.","journal-title":"Cancer Commun"},{"issue":"2","key":"5091_CR2","first-page":"E259","volume":"61","author":"M Mohammadian","year":"2020","unstructured":"Mohammadian M, Bakeshei KA, Mohammadian-Hafshejani A. International epidemiology of liver cancer: geographical distribution, secular trends and predicting the future. J Prev Med Hyg. 2020;61(2):E259.","journal-title":"J Prev Med Hyg"},{"key":"5091_CR3","doi-asserted-by":"publisher","first-page":"4558782","DOI":"10.1155\/2022\/4558782","volume":"2022","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Ouyang Y, Fang K, Sun G, Tu S, Xin W, et al. Prediction of prognosis and molecular mechanism of ferroptosis in hepatocellular carcinoma based on bioinformatics methods. Comput Math Methods Med. 2022;2022:4558782.","journal-title":"Comput Math Methods Med"},{"issue":"3","key":"5091_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000514174","volume":"10","author":"M Kudo","year":"2021","unstructured":"Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, et al. Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update. Liver Cancer. 2021;10(3):181\u2013223.","journal-title":"Liver Cancer"},{"issue":"1","key":"5091_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5582\/bst.2022.01061","volume":"16","author":"N Wen","year":"2022","unstructured":"Wen N, Cai Y, Li F, Ye H, Tang W, Song P, et al. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update. Biosci Trends. 2022;16(1):20\u201330.","journal-title":"Biosci Trends"},{"issue":"10","key":"5091_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12032-022-01750-8","volume":"39","author":"Q Liu","year":"2022","unstructured":"Liu Q, Du X, Yu Z, Yao Q, Meng X, Zhang K, et al. STARD5 as a potential clinical target of hepatocellular carcinoma. Med Oncol (Northwood Lond Engl). 2022;39(10):156.","journal-title":"Med Oncol (Northwood Lond Engl)"},{"key":"5091_CR7","doi-asserted-by":"publisher","first-page":"m3544","DOI":"10.1136\/bmj.m3544","volume":"371","author":"JD Yang","year":"2020","unstructured":"Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ. 2020;371:m3544.","journal-title":"BMJ"},{"issue":"6586","key":"5091_CR8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.abo3959","volume":"375","author":"MA Kahlson","year":"2022","unstructured":"Kahlson MA, Dixon SJ. Copper-induced cell death. Science (New York, NY). 2022;375(6586):1231\u20132.","journal-title":"Science (New York, NY)"},{"issue":"6586","key":"5091_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361.","journal-title":"Science"},{"issue":"2","key":"5091_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1039\/C6MT00202A","volume":"9","author":"S Blockhuys","year":"2017","unstructured":"Blockhuys S, Celauro E, Hildesj\u00f6 C, Feizi A, St\u00e5l O, Fierro-Gonz\u00e1lez J, et al. Defining the human copper proteome and analysis of its expression variation in cancers. Metallomics. 2017;9(2):112\u201323.","journal-title":"Metallomics"},{"key":"5091_CR11","doi-asserted-by":"publisher","first-page":"930041","DOI":"10.3389\/fphar.2022.930041","volume":"13","author":"H Lv","year":"2022","unstructured":"Lv H, Liu X, Zeng X, Liu Y, Zhang C, Zhang Q, et al. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in melanoma. Front Pharmacol. 2022;13:930041.","journal-title":"Front Pharmacol"},{"key":"5091_CR12","doi-asserted-by":"publisher","first-page":"8489387","DOI":"10.1155\/2022\/8489387","volume":"2022","author":"J Han","year":"2022","unstructured":"Han J, Hu Y, Liu S, Jiang J, Wang H. A newly established cuproptosis-associated long non-coding RNA signature for predicting prognosis and indicating immune microenvironment features in soft tissue sarcoma. J Oncol. 2022;2022:8489387.","journal-title":"J Oncol"},{"issue":"11","key":"5091_CR13","doi-asserted-by":"publisher","first-page":"15501","DOI":"10.18632\/aging.203106","volume":"13","author":"G Han","year":"2021","unstructured":"Han G, Guo Q, Ma N, Bi W, Xu M, Jia J, et al. LncRNA BCRT1 facilitates osteosarcoma progression via regulating miR-1303\/FGF7 axis. Aging (Albany NY). 2021;13(11):15501.","journal-title":"Aging (Albany NY)"},{"key":"5091_CR14","doi-asserted-by":"publisher","first-page":"718876","DOI":"10.3389\/fonc.2021.718876","volume":"11","author":"J Xiong","year":"2021","unstructured":"Xiong J, Wu L, Huang L, Wu C, Liu Z, Deng W, et al. LncRNA FOXP4-AS1 promotes progression of ewing sarcoma and is associated with immune infiltrates. Front Oncol. 2021;11:718876.","journal-title":"Front Oncol"},{"issue":"7","key":"5091_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41419-022-04880-z","volume":"13","author":"HN Ma","year":"2022","unstructured":"Ma HN, Chen HJ, Liu JQ, Li WT. Long non-coding RNA DLEU1 promotes malignancy of breast cancer by acting as an indispensable coactivator for HIF-1\u03b1-induced transcription of CKAP2. Cell Death Dis. 2022;13(7):625.","journal-title":"Cell Death Dis"},{"issue":"1","key":"5091_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-021-04123-6","volume":"22","author":"S Yang","year":"2021","unstructured":"Yang S, Zhou Y, Zhang X, Wang L, Fu J, Zhao X, et al. The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma. BMC Bioinform. 2021;22(1):1\u201316.","journal-title":"BMC Bioinform"},{"key":"5091_CR17","doi-asserted-by":"publisher","first-page":"719175","DOI":"10.3389\/fimmu.2021.719175","volume":"12","author":"Z Xu","year":"2021","unstructured":"Xu Z, Peng B, Liang Q, Chen X, Cai Y, Zeng S, et al. Construction of a Ferroptosis-Related Nine-lncRNA Signature for predicting prognosis and immune response in hepatocellular carcinoma. Front Immunol. 2021;12:719175.","journal-title":"Front Immunol"},{"issue":"6","key":"5091_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1042\/BSR20210760","volume":"41","author":"L Li","year":"2021","unstructured":"Li L, Xie R, Lu G. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Biosci Rep. 2021;41(6):760.","journal-title":"Biosci Rep"},{"key":"5091_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.707707","volume":"12","author":"C Lupton-Smith","year":"2021","unstructured":"Lupton-Smith C, Stuart EA, McGinty EE, Dalcin AT, Jerome GJ, Wang NY, et al. Determining predictors of weight loss in a behavioral intervention: a case study in the use of lasso regression. Front Psych. 2021;12: 707707.","journal-title":"Front Psych"},{"key":"5091_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.807418","volume":"9","author":"L Yin","year":"2022","unstructured":"Yin L, Zhou L, Gao S, Feng Y, Zhu H, Xiang J, et al. Classification of hepatocellular carcinoma based on N6-methylandenosine-related lncRNAs profiling. Front Mol Biosci. 2022;9: 807418.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"5091_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"5091_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14(1):1\u201315.","journal-title":"BMC Bioinform"},{"key":"5091_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105241","volume":"116","author":"MJ Awan","year":"2021","unstructured":"Awan MJ, Gittleman H, Barnholtz-Sloan J, Machtay M, Nguyen-Tan PF, Rosenthal DI, et al. Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores\u2014a pooled analysis of RTOG 0129 and 0522. Oral Oncol. 2021;116: 105241.","journal-title":"Oral Oncol"},{"issue":"1","key":"5091_CR24","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"D1","key":"5091_CR25","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"5091_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9(9): e107468.","journal-title":"PLoS ONE"},{"key":"5091_CR27","first-page":"7488188","volume":"2021","author":"Z Li","year":"2021","unstructured":"Li Z, Li Y, Zhong W, Huang P. m6A-related lncRNA to develop prognostic signature and predict the immune landscape in bladder cancer. J Oncol. 2021;2021:7488188.","journal-title":"J Oncol"},{"issue":"1","key":"5091_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"5091_CR29","doi-asserted-by":"publisher","first-page":"W423","DOI":"10.1093\/nar\/gkn282","volume":"36","author":"S Okuda","year":"2008","unstructured":"Okuda S, Yamada T, Hamajima M, Itoh M, Katayama T, Bork P, et al. KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res. 2008;36(Web Server issue):W423\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"5091_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"5091_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"5091_CR32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524\u201348.","journal-title":"JAMA Oncol"},{"key":"5091_CR33","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet Lond Engl. 2018;391:1301\u201314.","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"5091_CR34","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.1038\/s41598-022-14554-7","volume":"12","author":"L Luo","year":"2022","unstructured":"Luo L, Yao X, Xiang J, Huang F, Luo H. Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma. Sci Rep. 2022;12(1):10007.","journal-title":"Sci Rep"},{"issue":"29","key":"5091_CR35","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.3748\/wjg.v23.i29.5282","volume":"23","author":"D Dimitroulis","year":"2017","unstructured":"Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, et al. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23(29):5282.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"5091_CR36","first-page":"635","volume":"93","author":"F Braun","year":"2022","unstructured":"Braun F, Sch\u00e4fer JP, Dobbermann H, Becker T, Linecker M. Hepatocellular carcinoma. Chirurgie (Heidelberg, Germany). 2022;93(7):635\u201343.","journal-title":"Chirurgie (Heidelberg, Germany)"},{"issue":"5","key":"5091_CR37","first-page":"505","volume":"2","author":"S Gallage","year":"2021","unstructured":"Gallage S, Garc\u00eda-Beccaria M, Szydlowska M, Rahbari M, Mohr R, Tacke F, et al. The therapeutic landscape of hepatocellular carcinoma. Med (New York, NY). 2021;2(5):505\u201352.","journal-title":"Med (New York, NY)"},{"issue":"5","key":"5091_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P. The molecular machinery of regulated cell death. Cell Res. 2019;29(5):347\u201364.","journal-title":"Cell Res"},{"key":"5091_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105766","volume":"147","author":"S Azadifar","year":"2022","unstructured":"Azadifar S, Rostami M, Berahmand K, Moradi P, Oussalah M. Graph-based relevancy-redundancy gene selection method for cancer diagnosis. Comput Biol Med. 2022;147: 105766.","journal-title":"Comput Biol Med"},{"key":"5091_CR40","doi-asserted-by":"publisher","first-page":"107034","DOI":"10.1016\/j.knosys.2021.107034","volume":"223","author":"OA Alomari","year":"2021","unstructured":"Alomari OA, Makhadmeh SN, Al-Betar MA, Alyasseri ZAA, Doush IA, Abasi AK, et al. Gene selection for microarray data classification based on Gray Wolf Optimizer enhanced with TRIZ-inspired operators. Knowl Based Syst. 2021;223:107034.","journal-title":"Knowl Based Syst"},{"key":"5091_CR41","doi-asserted-by":"publisher","first-page":"108230","DOI":"10.1016\/j.mbs.2019.108230","volume":"315","author":"AK Shukla","year":"2019","unstructured":"Shukla AK, Tripathi D. Identification of potential biomarkers on microarray data using distributed gene selection approach. Math Biosci. 2019;315:108230.","journal-title":"Math Biosci"},{"key":"5091_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.907859","volume":"13","author":"M Chen","year":"2022","unstructured":"Chen M, Wu GB, Hua S, Zhao ZF, Li HJ, Luo M. Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma. Front Genet. 2022;13: 907859.","journal-title":"Front Genet"},{"key":"5091_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.949110","volume":"13","author":"R Sun","year":"2022","unstructured":"Sun R, Wang X, Chen J, Teng D, Chan S, Tu X, et al. Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma. Front Genet. 2022;13: 949110.","journal-title":"Front Genet"},{"issue":"9","key":"5091_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10612","volume":"8","author":"Y Xu","year":"2022","unstructured":"Xu Y, Liu R. Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma. Heliyon. 2022;8(9): e10612.","journal-title":"Heliyon"},{"issue":"1","key":"5091_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-021-03399-z","volume":"12","author":"H Fan","year":"2021","unstructured":"Fan H, Yuan J, Li Y, Jia Y, Li J, Wang X, et al. MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p\/BRD4 axis. Cell Death Dis. 2021;12(1):128.","journal-title":"Cell Death Dis"},{"issue":"4","key":"5091_CR46","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ijrobp.2016.07.036","volume":"96","author":"R Zheng","year":"2016","unstructured":"Zheng R, Yao Q, Ren C, Liu Y, Yang H, Xie G, et al. Upregulation of long noncoding RNA small nucleolar RNA host gene 18 promotes radioresistance of glioma by repressing semaphorin 5A. Int J Radiat Oncol Biol Phys. 2016;96(4):877\u201387.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5091_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.726745","volume":"11","author":"K Huang","year":"2021","unstructured":"Huang K, Yue X, Zheng Y, Zhang Z, Cheng M, Li L, et al. Development and validation of an mesenchymal-related long non-coding RNA prognostic model in glioma. Front Oncol. 2021;11: 726745.","journal-title":"Front Oncol"},{"issue":"8","key":"5091_CR48","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA. The complex role of tumor-infiltrating macrophages. Nat Immunol. 2022;23(8):1148\u201356.","journal-title":"Nat Immunol"},{"key":"5091_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L. Shaping polarization of tumor-associated macrophages in cancer immunotherapy. Front Immunol. 2022;13: 888713.","journal-title":"Front Immunol"},{"issue":"1","key":"5091_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-022-01307-2","volume":"15","author":"L Xu","year":"2022","unstructured":"Xu L, Zou C, Zhang S, Chu TSM, Zhang Y, Chen W, et al. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. J Hematol Oncol. 2022;15(1):87.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"5091_CR51","doi-asserted-by":"publisher","first-page":"e85841","DOI":"10.1172\/jci.insight.85841","volume":"1","author":"K Gabrusiewicz","year":"2016","unstructured":"Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, et al. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight. 2016;1(2):e85841.","journal-title":"JCI Insight"},{"issue":"9","key":"5091_CR52","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.18632\/aging.103147","volume":"12","author":"L Huang","year":"2020","unstructured":"Huang L, Wang Z, Chang Y, Wang K, Kang X, Huang R, et al. EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma. Aging (Albany NY). 2020;12(9):8397.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"5091_CR53","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12885-022-09872-y","volume":"22","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zou J, Chen R. An M0 macrophage-related prognostic model for hepatocellular carcinoma. BMC Cancer. 2022;22(1):791.","journal-title":"BMC Cancer"},{"issue":"1","key":"5091_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12905-022-01667-4","volume":"22","author":"H Liu","year":"2022","unstructured":"Liu H, Cheng Y. Identification of autophagy-related long non-coding RNAs in endometrial cancer via comprehensive bioinformatics analysis. BMC Womens Health. 2022;22(1):85.","journal-title":"BMC Womens Health"},{"key":"5091_CR55","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.2147\/IJGM.S336403","volume":"14","author":"R Shi","year":"2021","unstructured":"Shi R, Wang Z, Zhang J, Yu Z, An L, Wei S, et al. N6-methyladenosine-related long noncoding rnas as potential prognosis biomarkers for endometrial cancer. Int J Gen Med. 2021;14:8249\u201362.","journal-title":"Int J Gen Med"},{"issue":"27","key":"5091_CR56","doi-asserted-by":"publisher","first-page":"e2026271118","DOI":"10.1073\/pnas.2026271118","volume":"118","author":"L Ducimeti\u00e8re","year":"2021","unstructured":"Ducimeti\u00e8re L, Lucchiari G, Litscher G, Nater M, Heeb L, Nu\u00f1ez NG, et al. Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis. Proc Natl Acad Sci USA. 2021;118(27):e2026271118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"5091_CR57","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41590-022-01213-2","volume":"23","author":"ER Kansler","year":"2022","unstructured":"Kansler ER, Dadi S, Krishna C, Nixon BG, Stamatiades EG, Liu M, et al. Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies. Nat Immuol. 2022;23(6):904\u201315.","journal-title":"Nat Immuol"},{"key":"5091_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.893177","volume":"13","author":"SJ Judge","year":"2022","unstructured":"Judge SJ, Bloomstein JD, Sholevar CJ, Darrow MA, Stoffel KM, Vick LV, et al. Transcriptome analysis of tumor-infiltrating lymphocytes identifies NK cell gene signatures associated with lymphocyte infiltration and survival in soft tissue sarcomas. Front Immunol. 2022;13: 893177.","journal-title":"Front Immunol"},{"issue":"14","key":"5091_CR59","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.3390\/ijms23147859","volume":"23","author":"C Fionda","year":"2022","unstructured":"Fionda C, Scarno G, Stabile H, Molfetta R, Di Censo C, Gismondi A, et al. NK cells and other cytotoxic innate lymphocytes in colorectal cancer progression and metastasis. Int J Mol Sci. 2022;23(14):7859.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5091_CR60","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12920-019-0571-y","volume":"12","author":"Y Yin","year":"2019","unstructured":"Yin Y, Li B, Mou K, Khan MT, Kaushik AC, Wei D, et al. Stoichioproteomics reveal oxygen usage bias, key proteins and pathways in glioma. BMC Med Genomics. 2019;12(1):125.","journal-title":"BMC Med Genomics"},{"issue":"1638","key":"5091_CR61","first-page":"20130094","volume":"369","author":"D Urrego","year":"2014","unstructured":"Urrego D, Tomczak AP, Zahed F, St\u00fchmer W. Pardo LAJPTotRSBBS. Potassium channels in cell cycle and cell proliferation. 2014;369(1638):20130094.","journal-title":"Potassium channels in cell cycle and cell proliferation"},{"issue":"1","key":"5091_CR62","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12885-022-09398-3","volume":"22","author":"Y Li","year":"2022","unstructured":"Li Y, Xiong H. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K\/AKT\/mTOR and Ras\/RAF\/MAPK pathways. BMC Cancer. 2022;22(1):298.","journal-title":"BMC Cancer"},{"key":"5091_CR63","first-page":"153","volume":"407","author":"M Aoki","year":"2017","unstructured":"Aoki M, Fujishita T. Oncogenic roles of the PI3K\/AKT\/mTOR axis. Curr Top Microbiol Immunol. 2017;407:153\u201389.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"5091_CR64","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3892\/ol.2021.12795","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y, Yang S, Wang F, Zhou Z, Xu W, Xie J, et al. PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K\/AKT signaling pathway. Oncol Lett. 2021;22(1):534.","journal-title":"Oncol Lett"},{"key":"5091_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.knosys.2022.109884","volume":"256","author":"F Saberi-Movahed","year":"2022","unstructured":"Saberi-Movahed F, Rostami M, Berahmand K, Karami S, Tiwari P, Oussalah M, et al. Dual Regularized Unsupervised Feature Selection Based on Matrix Factorization and Minimum Redundancy with application in gene selection. Knowl Based Syst. 2022;256: 109884.","journal-title":"Knowl Based Syst"},{"key":"5091_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2021.102228","volume":"123","author":"M Rostami","year":"2022","unstructured":"Rostami M, Forouzandeh S, Berahmand K, Soltani M, Shahsavari M, Oussalah M. Gene selection for microarray data classification via multi-objective graph theoretic-based method. Artif Intell Med. 2022;123: 102228.","journal-title":"Artif Intell Med"},{"key":"5091_CR67","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.swevo.2019.03.015","volume":"48","author":"Y Guo","year":"2019","unstructured":"Guo Y, Yang H, Chen M, Cheng J, Gong DJS. Ensemble prediction-based dynamic robust multi-objective optimization methods. Swarm Evol Comput. 2019;48:156\u201371.","journal-title":"Swarm Evol Comput"},{"key":"5091_CR68","doi-asserted-by":"publisher","first-page":"144168","DOI":"10.1016\/j.gene.2019.144168","volume":"726","author":"F Morais-Rodrigues","year":"2020","unstructured":"Morais-Rodrigues F, Silerio-Machado R, Kato RB, Rodrigues DLN, Valdez-Baez J, Fonseca V, et al. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression. Gene. 2020;726:144168.","journal-title":"Gene"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-05091-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-022-05091-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-05091-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T11:04:12Z","timestamp":1672743852000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-022-05091-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5091"],"URL":"https:\/\/doi.org\/10.1186\/s12859-022-05091-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2016019\/v1","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each patient included in Cancer Genome Atlas database has given a consent form for approving the data usage and publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}